Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Richard Schulof"'
Autor:
James J. Stark, Robert O. Dillman, Gamini Soori, Michael C. Wiemann, Richard Schulof, Neil M. Barth, Pamela J. Honeycutt
Publikováno v:
Cancer. 82:1677-1681
BACKGROUND The treatment of metastatic melanoma remains unsatisfactory despite encouraging results with biotherapy and combination chemotherapy. Combining these two modalities may improve outcomes for such patients. METHODS Patients who were eligible
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2a8b3835d419349f800a00aba223fd15
https://doi.org/10.1002/(sici)1097-0142(19980501)82:9<1677::aid-cncr13>3.0.co
https://doi.org/10.1002/(sici)1097-0142(19980501)82:9<1677::aid-cncr13>3.0.co
Autor:
Jashvir Khurana, Dennis Priebat, Kathleen Patterson, Richard Schulof, Richard G. Buch, Martin M. Malawer, Barry Shmookler, Gregory H. Reaman, Barry Potter
Publikováno v:
Clinical orthopaedics and related research. (270)
The authors assessed the impact of two cycles of preoperative chemotherapy (POCT) with intraarterial cisplatin (120 mg/m2) and continuous intravenous doxorubicin hydrochloride (Adriamycin; 20 mg/m2/day x 3 days) on the decision to perform a limb-spar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62b834bfa270be53fa0129efd528f88c
https://pubmed.ncbi.nlm.nih.gov/1884542
https://pubmed.ncbi.nlm.nih.gov/1884542